ESPE Abstracts (2015) 84 P-2-342


Changes in Insulin Sensitivity in Adolescents Who Underwent Bariatric Surgery: Effects of Laparoscopic Sleeve Gastrectomy and Laparoscopic Gastric Banding

Gianpaolo De Filippoa, Guillaume Pourcherb, Naziha Khen-Dunlopc, Christèle Kyhenga, Ibrahim Dagherb & Pierre Bougnèresa


aService de Médecine des Adolescents, Assistance Publique-Hôpitaux de Paris, Hôpitaux Universitaires Paris Sud, CHU Bicêtre, Le Kremlin-Bicêtre, France; bService de Chirurgie Viscérale Mini-Invasive, Assistance Publique-Hôpitaux de Paris, Hôpitaux Universitaires Paris Sud, Hôpital Antoine Béclère, Clamart, France; cService de Chirurgie Viscérale Pédiatrique, Assistance Publique-Hôpitaux de Paris, Hôpitaux Universitaires Paris Centre, Hôpital Necker-Enfants Malades, Paris, France

Background: In adults, bariatric surgery has gradually emerged as a ‘metabolic’ surgery, able to rapidly improve metabolic disturbances linked to severe obesity. Even if type 2 diabetes is rare in european obese adolescents, alterations in insulin sensitivity are present in almost all.

Objective and hypotheses: To evaluate the modification of insulin resistance (IR) and insulin sensitivity (IS) in severe obese adolescents who underwent bariatric surgery, comparing two methods: laparoscopic sleeve gastrectomy (LSG) and laparoscopic gastric banding (LGB).

Method: Forty patients followed for 12 months were studied. 20 underwent LSG (mean age 17.14±1.46 years, BMI 44.73±9.37; Z-score 4.7±0.95) and 20 underwent LGB (mean age 15.55±1.9 years; BMI 37.86±4.12; Z-score +4.48±0.68). IR was estimated by homeostasis model of assessment (HOMA-IR). The IS was evaluated by quantitative insulin sensitivity check index (QUICKI).

Results: Among patients who underwent LSG, improvement in IR was significant after 6 months (baseline HOMA-IR 4.7±0.95 vs 3.35±2.0 at T6, P=0.036) and 12 months (2.089±2.11). Normalisation of IS was observed in all patients after 6 months (baseline QUICKI 0.29±0.01; 0.34±0.03 at T6, P=0.020). The change in IS was not correlated with weight loss. In LGB patients, improvement of IS was slower, showing a trend without reaching significance (baseline HOMA-IR 4.87±2.62 vs 4.26±2.54 at T6, 3.95±3.20 at T12, baseline QUICKI 0.29±0.01, 0.31±0.02 at T6 and 0.32±0.03 at T12) and it was correlated to weight loss (P<0.001).

Conclusion: Our observation confirms the metabolic benefits of LSG even in a cohort of very young patients. Unlike LGB, the improvement of insulin sensitivity is sharp and not correlated to weight loss.

Article tools

My recent searches

No recent searches.

My recently viewed abstracts

No recent abstracts.